Clinical Trials Directory

Trials / Completed

CompletedNCT03673995

Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

Use of Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
186 (actual)
Sponsor
Pharmarte srl · Industry
Sex
Female
Age
16 Years – 38 Years
Healthy volunteers
Not accepted

Summary

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMyo-inositol+L-tyrosinePCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal, hirsutism and ovulation assesment.

Timeline

Start date
2017-05-02
Primary completion
2018-08-22
Completion
2018-10-30
First posted
2018-09-17
Last updated
2020-06-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03673995. Inclusion in this directory is not an endorsement.